Handa Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Handa Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 36.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Jan 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2,550 | 2,080 | 1,910 | 1,914 | 1 |
12/31/2023 | 1,106 | 727 | 667 | 668 | N/A |
9/30/2023 | 956 | 707 | 394 | 394 | N/A |
6/30/2023 | 723 | 540 | 79 | 80 | N/A |
3/31/2023 | 460 | 250 | -67 | -66 | N/A |
12/31/2022 | 198 | -40 | -212 | -212 | N/A |
9/30/2022 | 56 | -173 | -162 | -160 | N/A |
6/30/2022 | 56 | -217 | -135 | -134 | N/A |
3/31/2022 | 43 | -233 | -161 | -157 | N/A |
12/31/2021 | 29 | -248 | -186 | -179 | N/A |
9/30/2021 | 29 | -250 | -242 | -233 | N/A |
6/30/2021 | 29 | -253 | -298 | -286 | N/A |
3/31/2021 | 29 | -268 | -307 | -297 | N/A |
12/31/2020 | 29 | -282 | -316 | -308 | N/A |
9/30/2020 | 34 | -273 | -276 | -271 | N/A |
6/30/2020 | 38 | -263 | -237 | -234 | N/A |
3/31/2020 | 61 | -220 | -236 | -235 | N/A |
12/31/2019 | 84 | -178 | -236 | -235 | N/A |
9/30/2019 | 93 | -160 | -243 | -236 | N/A |
6/30/2019 | 103 | -141 | -250 | -237 | N/A |
3/31/2019 | 98 | -154 | -220 | -207 | N/A |
12/31/2018 | 94 | -167 | -191 | -177 | N/A |
9/30/2018 | 81 | -167 | -156 | -148 | N/A |
6/30/2018 | 69 | -167 | -122 | -118 | N/A |
3/31/2018 | 303 | 63 | 167 | 173 | N/A |
12/31/2017 | 538 | 293 | 456 | 464 | N/A |
9/30/2017 | 620 | 368 | N/A | 465 | N/A |
6/30/2017 | 702 | 442 | N/A | 467 | N/A |
3/31/2017 | 457 | 235 | N/A | 167 | N/A |
12/31/2016 | 211 | 29 | N/A | -133 | N/A |
9/30/2016 | 119 | -43 | N/A | -138 | N/A |
6/30/2016 | 28 | -115 | N/A | -143 | N/A |
3/31/2016 | 14 | -121 | N/A | -126 | N/A |
12/31/2015 | N/A | -128 | N/A | -109 | N/A |
12/31/2014 | 3 | -17 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6620's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 6620's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 6620's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6620's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 6620's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6620's Return on Equity is forecast to be high in 3 years time